In the study presented here, we reveal that combining the two FDA-approved antimetabolic drugs, metformin and L-asparaginase, induces significant DLBCL cell apoptosis that was not observed upon treatment with either drug alone, in both OxPhos and BCR/glycolytic DLBCL cells. The gene discussed is ASPG; the disease is diffuse large B-cell lymphoma.